Understanding Primary Aldosteronism
At a Glance
Primary Aldosteronism (PA) is a common, treatable condition where the adrenal glands produce excess aldosterone, causing difficult-to-control high blood pressure. Often misdiagnosed, it requires specific hormone screening and targeted therapies to protect your heart and kidneys.
If you have struggled to control your high blood pressure despite taking multiple medications, you may have been told you have “essential hypertension”—a term doctors use when the cause is unknown. However, for many people, the cause is very specific: a condition called Primary Aldosteronism (PA), also known as Conn’s Syndrome.
Primary Aldosteronism occurs when your adrenal glands (two small glands located on top of your kidneys) produce too much of a hormone called aldosterone [1]. This hormone regulates the balance of salt and water in your body. When you have too much of it, your body holds onto excess salt and water, which drives up your blood pressure and can cause damage to your heart, kidneys, and blood vessels [2][3].
A Hidden Epidemic
For decades, PA was taught in medical schools as a rare condition that only affected about 1% of people with high blood pressure. We now know this is incorrect. Research shows that PA is the most common cause of “secondary” hypertension (high blood pressure caused by a specific, identifiable condition) [4].
- General Hypertension: It is estimated that 5% to 13% of all people with high blood pressure actually have PA [4][5].
- Resistant Hypertension: For those whose blood pressure remains high despite taking three or more medications, the rate jumps to nearly 20% [6][7].
Shifting the Paradigm: From “Rare” to a “Spectrum”
Medical understanding of PA has changed significantly in recent years. Doctors used to view PA as a “binary” disease—you either had a large tumor on one adrenal gland or you didn’t.
Today, experts recognize PA as a continuum of autonomous aldosterone production [8]. This means the disease exists on a spectrum [9]:
- Mild/Subclinical: Your body produces slightly too much aldosterone, which may not cause severe high blood pressure yet but can still begin to strain your cardiovascular system [10].
- Overt PA: The hormone production is so high that it causes severe, difficult-to-treat hypertension and may lead to low potassium levels [11].
Why is it Often Overlooked?
Many primary care doctors do not routinely screen for PA because of two common “clinical pitfalls”:
- The Potassium Myth: In the past, doctors only looked for PA if a patient had low potassium (hypokalemia). However, we now know that most people with PA actually have normal potassium levels [12].
- The “Essential” Label: Because PA is so common, it is often misdiagnosed as standard “essential” hypertension [1]. Doctors may simply keep adding more generic blood pressure medications rather than testing for the underlying hormonal cause [13].
Three Stabilizing Facts
If you are concerned you might have PA, it is important to keep these facts in mind:
- It is a distinct disease: PA is not your fault. It is not caused by poor diet or lack of exercise; it is a physical, hormonal imbalance that requires a specific diagnosis [1].
- It is highly treatable (and sometimes curable): If the excess hormone is coming from only one adrenal gland, the condition can often be cured with a minimally invasive surgery [14]. If it affects both glands, it can be managed very effectively with specific medications called mineralocorticoid receptor antagonists (MRAs) [15].
- You deserve a targeted approach: Standard blood pressure drugs often fail to protect the heart and kidneys of PA patients because they don’t block the toxic effects of excess aldosterone [15]. Getting the right diagnosis allows for the right protection [16].
In This Guide
Explore the pages below to understand your diagnosis, prepare for testing, and explore treatment options.
Recognizing the Symptoms and Warning Signs
Learn the hidden symptoms of primary aldosteronism. Discover why resistant hypertension, sleep apnea, and even normal potassium levels can be warning signs.
The Biology and Subtypes of the Disease
Learn about the biology of Primary Aldosteronism (PA). Understand the differences between APA and IHA subtypes, genetic causes, and why subtyping matters.
The Diagnostic Journey: Screening and Confirmatory Testing
Learn about the diagnostic journey for Primary Aldosteronism. Understand the Aldosterone-to-Renin Ratio (ARR), medication washouts, and confirmatory tests.
Mapping the Problem: Finding the Source
Learn how doctors find the source of Primary Aldosteronism (PA). Understand the role of CT scans, Adrenal Venous Sampling (AVS), and new PET imaging options.
Surgical Treatment: The Path to a Cure
Learn what to expect from unilateral adrenalectomy for primary aldosteronism (PA). Understand PASO success rates, recovery, and blood pressure outcomes.
Medical Management: Blocking the Hormone’s Effects
Learn about medical management for bilateral primary aldosteronism (PA). Understand how MRA medications like spironolactone work and PAMO success criteria.
Life After Treatment: The Road to Recovery
Discover what to expect during primary aldosteronism recovery. Learn about heart healing, kidney function changes, mental health, and long-term monitoring.
Common questions in this guide
Can I have primary aldosteronism if my potassium levels are normal?
What causes primary aldosteronism?
Why do standard blood pressure medications fail to treat this condition?
How do doctors test for primary aldosteronism?
Is primary aldosteronism curable?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my history of resistant hypertension, what is my specific risk for primary aldosteronism?
- 2.If my potassium levels have always been 'normal,' does that mean we can definitely rule out primary aldosteronism?
- 3.Can we order an aldosterone-to-renin ratio (ARR) test to screen for this condition?
- 4.Are my current blood pressure medications (like diuretics or beta-blockers) going to interfere with the accuracy of a screening test?
- 5.If the screening comes back positive, do you manage the next steps or should I see a specialized endocrinologist?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Prevalence of primary aldosteronism and screening indications.
Ruiz-Sanchez JG
Vitamins and hormones 2026; (130()):43-67 doi:10.1016/bs.vh.2025.08.001.
PMID: 41638804 - 2
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study.
Brown JM, Wijkman MO, Claggett BL, et al.
Hypertension (Dallas, Tex. : 1979) 2022; (79(9)):1984-1993 doi:10.1161/HYPERTENSIONAHA.122.19134.
PMID: 35582954 - 3
Aldosterone: Essential for Life but Damaging to the Vascular Endothelium.
Crompton M, Skinner LJ, Satchell SC, Butler MJ
Biomolecules 2023; (13(6)) doi:10.3390/biom13061004.
PMID: 37371584 - 4
The Potential Role of Primary Care in Case Detection/Screening of Primary Aldosteronism.
Kline GA, Prebtani APH, Leung AA, Schiffrin EL
American journal of hypertension 2017; (30(12)):1147-1150 doi:10.1093/ajh/hpx064.
PMID: 28992276 - 5
Primary Aldosteronism in Patients in China With Recently Detected Hypertension.
Xu Z, Yang J, Hu J, et al.
Journal of the American College of Cardiology 2020; (75(16)):1913-1922 doi:10.1016/j.jacc.2020.02.052.
PMID: 32327102 - 6
The adrenal gland and primary aldosteronism: anatomy, steroidogenesis, regulation, and genetic insights.
Long KC, Azizan EA
Frontiers in endocrinology 2025; (16()):1736534 doi:10.3389/fendo.2025.1736534.
PMID: 41601940 - 7
Screening for primary aldosteronism in the diabetic population: a cohort study.
Tan SJ, Libianto R, Yang J, Wong J
Internal medicine journal 2023; (53(5)):709-716 doi:10.1111/imj.15690.
PMID: 35000250 - 8
Primary aldosteronism - a multidimensional syndrome.
Turcu AF, Yang J, Vaidya A
Nature reviews. Endocrinology 2022; (18(11)):665-682 doi:10.1038/s41574-022-00730-2.
PMID: 36045149 - 9
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Vaidya A, Carey RM
The Journal of clinical endocrinology and metabolism 2020; (105(12)) doi:10.1210/clinem/dgaa606.
PMID: 32865201 - 10
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Brown JM, Siddiqui M, Calhoun DA, et al.
Annals of internal medicine 2020; (173(1)):10-20 doi:10.7326/M20-0065.
PMID: 32449886 - 11
Pathology of Aldosterone Biosynthesis and its Action.
Gao X, Yamazaki Y, Tezuka Y, et al.
The Tohoku journal of experimental medicine 2021; (254(1)):1-15 doi:10.1620/tjem.254.1.
PMID: 34011803 - 12
Hypertensive crisis due to secondary aldosteronism from polyarteritis nodosa.
Liu Y, Gong JY, Sydenham-Clarke LM, et al.
BMJ case reports 2026; (19(1)) doi:10.1136/bcr-2025-269055.
PMID: 41526073 - 13
Primary Aldosteronism: State-of-the-Art Review.
Vaidya A, Hundemer GL, Nanba K, et al.
American journal of hypertension 2022; (35(12)):967-988 doi:10.1093/ajh/hpac079.
PMID: 35767459 - 14
New advances in the diagnosis of primary aldosteronism.
Shen H, Xu ZX, Li QF
Chronic diseases and translational medicine 2020; (6(1)):1-5 doi:10.1016/j.cdtm.2019.12.009.
PMID: 32226929 - 15
Targeting the untargeted: Molecular insights and emerging therapeutic strategies for primary aldosteronism.
Lu H, Zhang Y, Qiu D, et al.
European journal of pharmacology 2026; (1029()):179035 doi:10.1016/j.ejphar.2026.179035.
PMID: 42208643 - 16
Pathogenesis of primary aldosteronism.
Parra Ramírez P, Martín Rojas-Marcos P
Vitamins and hormones 2026; (130()):27-41 doi:10.1016/bs.vh.2025.08.004.
PMID: 41638802
This page provides an educational overview of Primary Aldosteronism and its effects on blood pressure. It does not replace professional medical advice, diagnosis, or treatment from your endocrinologist or primary care doctor.
Get notified when new evidence is published on hyperaldosteronism.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.